Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes challenging immune and inflammatory phenomena. Though various therapeutic possibilities have been tested against coronavirus disease 2019 (COVID-19), the most adequate treatment has not yet been established. Propolis i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Pharmacother
Autors principals: Silveira, Marcelo Augusto Duarte, De Jong, David, Berretta, Andresa Aparecida, Galvão, Erica Batista dos Santos, Ribeiro, Juliana Caldas, Cerqueira-Silva, Thiago, Amorim, Thais Chaves, Conceição, Luis Filipe Miranda Rebelo da, Gomes, Marcel Miranda Dantas, Teixeira, Maurício Brito, Souza, Sergio Pinto de, Santos, Marcele Helena Celestino Alves dos, San Martin, Raissa Lanna Araújo, Silva, Márcio de Oliveira, Lírio, Monique, Moreno, Lis, Sampaio, Julio Cezar Miranda, Mendonça, Renata, Ultchak, Silviana Salles, Amorim, Fabio Santos, Ramos, João Gabriel Rosa, Batista, Paulo Benigno Pena, Guarda, Suzete Nascimento Farias da, Mendes, Ana Verena Almeida, Passos, Rogerio da Hora
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier Masson SAS. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980186/
https://ncbi.nlm.nih.gov/pubmed/34311528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111526
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars